[1]
2018. New Immunological Markers of Thromboembolic and Hemorrhagic Complications after Coronary Artery Bypass Grafting. Asian Journal of Pharmaceutics (AJP). 11, 04 (Feb. 2018). DOI:https://doi.org/10.22377/ajp.v11i04.1748.